Want to see INMB full AI Analyst Report?
Inmune Bio (INMB) Income Statement
Inmune Bio Income Statement
Last quarter (Q2 2026), Inmune Bio's total revenue was $0.00. In Q2, Inmune Bio's net income was $-1.27M. See Inmune Bio’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 50.00K | $ 14.00K | $ 155.00K | $ 374.00K | $ 181.00K | |
| $ 50.00K | $ 14.00K | $ 155.00K | $ 374.00K | $ 181.00K | |
| $ 30.92M | $ 42.65M | $ 29.90M | $ 26.32M | $ 29.33M | |
| Depreciation and Amortization | $ 84.00K | $ 553.00K | $ 29.74M | $ 25.95M | $ 29.15M |
| $ -45.85M | $ -41.53M | $ -267.00K | $ -1.35M | $ -1.19M | |
| $ -30.87M | $ -42.63M | $ -29.74M | $ -25.95M | $ -29.15M | |
| $ -15.06M | $ 553.00K | $ -267.00K | $ -1.35M | $ -1.19M | |
| $ -45.93M | $ -42.08M | $ -30.01M | $ -27.30M | $ -30.34M | |
| $ -45.93M | $ -42.08M | $ -30.01M | $ -27.30M | $ -30.34M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.86 | $ -2.11 | $ -1.67 | $ -1.52 | $ -1.88 |
| Diluted EPS | $ -1.86 | $ -2.11 | $ -1.67 | $ -1.52 | $ -1.88 |
| Weighted Average Shares Outstanding | 26.59M | 19.94M | 17.98M | 17.93M | 16.13M |
| Weighted Average Shares Outstanding (Diluted) | 26.59M | 19.94M | 17.98M | 17.93M | 16.13M |
Currency in USD
